Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, Dimitrios Bafaloukos, Athina Christopoulou et al.|Cancer Immunology Immunotherapy|2021Cited by 39
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, G. Koumakis, Georgia-Angeliki Koliou et al.|ESMO Open|2020Cited by 38
Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.Anna Koumarianou, George Fountzilas, I. Tzeveleki et al.|PubMed|2014Cited by 26